Assessing quality of life in cancer patients
1989

Assessing Quality of Life in Cancer Patients

publication Evidence: moderate

Author Information

Author(s): P. Maguire, P. Selby

Primary Institution: University of Manchester

Hypothesis

The study aims to identify and describe the damaging effects of cancer and its treatment on patients' quality of life.

Conclusion

The Rotterdam symptom checklist is currently the best tool for assessing key dimensions of quality of life in cancer patients.

Supporting Evidence

  • The study highlights the increasing recognition of the importance of measuring quality of life in cancer treatment.
  • The working party reviewed existing measures and provided guidance for clinical trialists.
  • The Rotterdam symptom checklist was found to be effective in measuring psychological dimensions.

Takeaway

This study looks at how cancer affects people's lives and suggests a good way to measure that impact.

Methodology

The working party assessed various quality of life instruments independently using agreed criteria.

Potential Biases

Some measures may not accurately reflect the quality of life due to reliance on clinician assessments.

Limitations

No single scale meets all clinical trial needs, and many existing measures lack validation in cancer patients.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication